uniQure (QURE) Non-Current Assets (2015 - 2026)
uniQure (QURE) recorded quarterly Non-Current Assets of $163.0 million in Q1 2026, down 3.53% quarter-over-quarter from $168.9 million in Q4 2025, and down 4.13% on a YoY basis from $170.0 million in Q1 2025.
uniQure (QURE) Non-Current Assets (2015 - 2026) Analysis & Trends
uniQure's Non-Current Assets history runs 12 years deep, the most recent figure standing at $163.0 million for Q1 2026.
- In Q1 2026, Non-Current Assets fell 4.13% year-over-year to $163.0 million; the TTM figure through Mar 2026 stood at $163.0 million (down 4.13% YoY), while the FY2025 annual figure was $168.9 million, up 1.61% from the prior year.
- Non-Current Assets was $163.0 million for Q1 2026 at uniQure, down from $168.9 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $228.2 million in Q4 2022 to a low of $138.9 million in Q2 2024.
- Historically, Non-Current Assets has averaged $176.6 million across 5 years, with a median of $176.3 million in 2025.
- The sharpest annual moves came in 2022 and 2024: Non-Current Assets surged 119.49% in 2022, then slipped 25.26% in 2024.
- A 5-year view of Non-Current Assets shows it stood at $228.2 million in 2022, then fell by 21.19% to $179.8 million in 2023, then slipped by 7.56% to $166.2 million in 2024, then climbed by 1.61% to $168.9 million in 2025, then fell by 3.53% to $163.0 million in 2026.
- The last three Non-Current Assets figures came in at $163.0 million (Q1 2026), $168.9 million (Q4 2025), and $172.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 62,953.78 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 39.71 Mn |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | 162.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 162.96 Mn |
| Dec 31, 2025 | 168.92 Mn |
| Sep 30, 2025 | 172.19 Mn |
| Jun 30, 2025 | 176.32 Mn |
| Mar 31, 2025 | 169.98 Mn |
| Dec 31, 2024 | 166.25 Mn |
| Sep 30, 2024 | 181.67 Mn |
| Jun 30, 2024 | 138.88 Mn |
| Mar 31, 2024 | 174.05 Mn |
| Dec 31, 2023 | 179.84 Mn |
| Sep 30, 2023 | 177.92 Mn |
| Jun 30, 2023 | 185.81 Mn |
| Mar 31, 2023 | 188.36 Mn |
| Dec 31, 2022 | 228.19 Mn |
| Sep 30, 2022 | 173.66 Mn |
| Jun 30, 2022 | 177.91 Mn |
| Mar 31, 2022 | 178.94 Mn |
| Dec 31, 2021 | 180.94 Mn |
| Sep 30, 2021 | 180.86 Mn |
| Jun 30, 2021 | 90.04 Mn |